← Open Payments lookup

ROBERT ROBY: Open Payments

NPI 1508809971 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$791 in 37 payments from 15 companies in 2025. Trend: 2023 $106 · 2024 $699 · 2025 $791

Food & beverage: $759Education: $32
CompanyPaymentsAmount
Novo Nordisk Inc8$183
AstraZeneca Pharmaceuticals LP6$135
Lilly USA, LLC6$108
SANOFI PASTEUR INC.2$58
GlaxoSmithKline, LLC.3$48
ABBVIE INC.2$47
Astellas Pharma US Inc2$39
Eisai Inc.1$34
Gilead Sciences, Inc.1$25
Bayer Healthcare Pharmaceuticals Inc.1$24

Products named: Ozempic, MOUNJARO, AIRSUPRA, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, QULIPTA, Veozah, Rybelsus, FARXIGA.

Industry payments across MD — which companies pay providers there.